Latest Kynam Capital Management, LP Stock Portfolio
$955Million
Equity Portfolio Value
Last Reported on: 15 May, 2024
About Kynam Capital Management, LP and it’s 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Kynam Capital Management, LP reported an equity portfolio of $955.5 Millions as of 31 Mar, 2024.
The top stock holdings of Kynam Capital Management, LP are NTRA, SNDX, CLDX. The fund has invested 19.1% of it's portfolio in NATERA INC and 14.1% of portfolio in SYNDAX PHARMACEUTICALS INC.
The fund managers got completely rid off IMMUNOGEN INC (IMGN), MORPHOSYS AG (MOR) and CENTESSA PHARMACEUTICALS PLC (CNTA) stocks. They significantly reduced their stock positions in VIRIDIAN THERAPEUTICS INC (VRDN), ACELYRIN INC and VERA THERAPEUTICS INC (VERA). Kynam Capital Management, LP opened new stock positions in IRONWOOD PHARMACEUTICALS INC (IRWD). The fund showed a lot of confidence in some stocks as they added substantially to DYNAVAX TECHNOLOGIES CORP (DVAX), TYRA BIOSCIENCES INC (TYRA) and COGENT BIOSCIENCES INC (COGT).
The top stock holdings of Kynam Capital Management, LP are NTRA, SNDX, CLDX. The fund has invested 19.1% of it's portfolio in NATERA INC and 14.1% of portfolio in SYNDAX PHARMACEUTICALS INC.
The fund managers got completely rid off IMMUNOGEN INC (IMGN), MORPHOSYS AG (MOR) and CENTESSA PHARMACEUTICALS PLC (CNTA) stocks. They significantly reduced their stock positions in VIRIDIAN THERAPEUTICS INC (VRDN), ACELYRIN INC and VERA THERAPEUTICS INC (VERA). Kynam Capital Management, LP opened new stock positions in IRONWOOD PHARMACEUTICALS INC (IRWD). The fund showed a lot of confidence in some stocks as they added substantially to DYNAVAX TECHNOLOGIES CORP (DVAX), TYRA BIOSCIENCES INC (TYRA) and COGENT BIOSCIENCES INC (COGT).
New Buys
| Ticker | $ Bought |
|---|---|
| IRONWOOD PHARMACEUTICALS INC | 14,153,800 |
New stocks bought by Kynam Capital Management, LP
Additions
| Ticker | % Inc. |
|---|---|
| DYNAVAX TECHNOLOGIES CORP | 179 |
| TYRA BIOSCIENCES INC | 51.44 |
| COGENT BIOSCIENCES INC | 45.18 |
| BIOCRYST PHARMACEUTICALS INC | 41.9 |
| BURNING ROCK BIOTECH LTD | 10.89 |
Additions to existing portfolio by Kynam Capital Management, LP
Reductions
| Ticker | % Reduced |
|---|---|
| VIRIDIAN THERAPEUTICS INC | -77.98 |
| ACELYRIN INC | -66.97 |
| VERA THERAPEUTICS INC | -58.17 |
| PROTAGONIST THERAPEUTICS INC | -42.93 |
| VAXCYTE INC | -25.68 |
| LIQUIDIA CORPORATION | -16.68 |
| NATERA INC | -16.67 |
| CELLDEX THERAPEUTICS INC NEW | -3.52 |
Kynam Capital Management, LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| MORPHOSYS AG | -41,923,400 |
| IMMUNOGEN INC | -42,177,200 |
| CENTESSA PHARMACEUTICALS PLC | -3,523,920 |
Kynam Capital Management, LP got rid off the above stocks
Current Stock Holdings of Kynam Capital Management, LP
Last Reported on: 15 May, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options |
|---|---|---|---|---|---|---|---|
| AMRN | AMARIN CORP PLC | 1.12 | 12,023,000 | 10,710,000 | UNCHANGED | 0.00 | |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 3.47 | 6,527,490 | 33,159,700 | ADDED | 41.9 | |
| BNR | BURNING ROCK BIOTECH LTD | 0.74 | 9,640,910 | 7,019,550 | ADDED | 10.89 | |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 12.74 | 2,900,000 | 121,713,000 | REDUCED | -3.52 | |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| COGT | COGENT BIOSCIENCES INC | 5.98 | 8,500,000 | 57,120,000 | ADDED | 45.18 | |
| CRBU | CARIBOU BIOSCIENCES INC | 0.58 | 1,068,530 | 5,492,230 | UNCHANGED | 0.00 | |
| DVAX | DYNAVAX TECHNOLOGIES CORP | 5.51 | 4,239,780 | 52,615,700 | ADDED | 179 | |
| IMGN | IMMUNOGEN INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 1.48 | 1,625,000 | 14,153,800 | NEW | ||
| LQDA | LIQUIDIA CORPORATION | 3.47 | 2,248,320 | 33,162,800 | REDUCED | -16.68 | |
| MOR | MORPHOSYS AG | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| NTRA | NATERA INC | 19.14 | 2,000,000 | 182,920,000 | REDUCED | -16.67 | |
| PCVX | VAXCYTE INC | 5.33 | 745,000 | 50,891,000 | REDUCED | -25.68 | |
| PTGX | PROTAGONIST THERAPEUTICS INC | 3.46 | 1,144,240 | 33,102,900 | REDUCED | -42.93 | |
| SNDX | SYNDAX PHARMACEUTICALS INC | 14.10 | 5,660,000 | 134,708,000 | UNCHANGED | 0.00 | |
| STRO | SUTRO BIOPHARMA INC | 1.18 | 2,001,730 | 11,309,800 | UNCHANGED | 0.00 | |
| TSVT | 2SEVENTY BIO INC | 3.33 | 5,953,820 | 31,853,000 | UNCHANGED | 0.00 | |
| TVTX | TRAVERE THERAPEUTICS INC | 1.61 | 2,000,000 | 15,420,000 | UNCHANGED | 0.00 | |
| TYRA | TYRA BIOSCIENCES INC | 0.88 | 515,190 | 8,449,120 | ADDED | 51.44 | |
| VERA | VERA THERAPEUTICS INC | 6.89 | 1,526,790 | 65,835,100 | REDUCED | -58.17 | |
| VRDN | VIRIDIAN THERAPEUTICS INC | 0.24 | 133,877 | 2,344,190 | REDUCED | -77.98 | |
| WVE | WAVE LIFE SCIENCES LTD | 2.54 | 3,932,080 | 24,260,900 | UNCHANGED | 0.00 | |
| ACELYRIN INC | 0.28 | 396,379 | 2,675,560 | REDUCED | -66.97 |